Zebra fish breast cancer 2, early onset (BRCA2) Control/blocking peptide
-
Catalog number
AB-23032-P
-
Price
Please ask
-
Size
100ug
-
-
Stock availability
Available
-
Category
Antibody Blocking Peptide
-
Antibody type
N/A
-
Antibody host
N/A
-
Antibody conjugate
N/A
-
Technical datasheet
Contact Gentaur to request the datasheet or ask our specialists for more information.
-
Notes
The Zebra fish breast cancer 2, early onset (BRCA2) Control/blocking peptide is manufactured for Research Use Only or for diagnostics purposes.
-
-
Test
You can block the antibody by the specific target amino acid sequence of peptide.
-
Properties
blocking peptide
-
Description
Isotype or positive controls by peptides, antibodies and deactivated samples. Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
-
Gene target
-
Gene symbol
BRCA2
-
Short name
Zebra fish breast cancer 2, early onset (BRCA2) Control/blocking peptide
-
Technique
blocking peptide, Blocking, Control, peptide, blocking peptides, adi made this blocking amino acid sequence or peptide to block the gene target in a volume of 1. For western blot it is often requested to block your antibody and to see the band of the analyzed protein disappear. This is called a negative control by blocking the WB antibody. controls, peptides
-
Species
Custom Service, Fishes
-
Alternative name
Zebra fluorescence-emitting hybridization breast cancer 2, early onset (breast cancer 2, early onset) reference/inhibiting short protein sequence
-
Alternative technique
control, peptides, controls
-
Alternative to gene target
breast cancer 2, early onset, BRCC2 and BROVCA2 and FACD and FAD and FAD1 and FANCD and FANCD1 and GLM3 and PNCA2, BRCA2 and IDBG-22703 and ENSG00000139618 and 675, gamma-tubulin binding, nuclei, Brca2 and IDBG-209587 and ENSMUSG00000041147 and 12190, BRCA2 and IDBG-630223 and ENSBTAG00000000988 and
-
Tissue
breast, control
-
Disease
cancer
-
Gene info
MeSH Data
-
Name
-
Concept
Scope note:
A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.
-
Tree numbers
- E01.370.225.500.620.670.325.350
- E01.370.225.750.600.670.325.350
- E05.200.500.620.670.325.350
- E05.200.750.600.670.325.350
- E05.393.285.350
- E05.393.661.475.350
-
Qualifiers
ethics, trends, veterinary, history, classification, economics, instrumentation, methods, standards, statistics & numerical data
Product images
Similar products